Concepts (286)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 27 | 2020 | 3639 | 1.900 |
Why?
|
| Contrast Media | 15 | 2020 | 1096 | 1.480 |
Why?
|
| Carcinogenesis | 3 | 2020 | 235 | 1.040 |
Why?
|
| Vanadates | 8 | 2009 | 32 | 1.020 |
Why?
|
| Triple Negative Breast Neoplasms | 2 | 2020 | 190 | 0.970 |
Why?
|
| Vanadium | 3 | 2015 | 13 | 0.870 |
Why?
|
| Gadolinium DTPA | 7 | 2017 | 255 | 0.820 |
Why?
|
| Electron Spin Resonance Spectroscopy | 15 | 2005 | 329 | 0.790 |
Why?
|
| Mammary Neoplasms, Animal | 3 | 2020 | 58 | 0.780 |
Why?
|
| Diet, High-Fat | 2 | 2020 | 134 | 0.730 |
Why?
|
| beta-Lactamases | 5 | 2004 | 57 | 0.620 |
Why?
|
| Arteries | 1 | 2020 | 181 | 0.610 |
Why?
|
| Spin Labels | 8 | 2013 | 107 | 0.600 |
Why?
|
| Mammary Glands, Animal | 5 | 2020 | 81 | 0.560 |
Why?
|
| Calcium Oxalate | 2 | 2015 | 188 | 0.550 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2020 | 276 | 0.540 |
Why?
|
| Feeding Behavior | 1 | 2020 | 338 | 0.540 |
Why?
|
| Mammary Neoplasms, Experimental | 2 | 2015 | 133 | 0.530 |
Why?
|
| Microscopy, Fluorescence | 3 | 2015 | 445 | 0.520 |
Why?
|
| Dietary Fats | 1 | 2017 | 137 | 0.500 |
Why?
|
| Durapatite | 1 | 2015 | 36 | 0.470 |
Why?
|
| Prostate | 2 | 2017 | 423 | 0.460 |
Why?
|
| Poloxamer | 3 | 2017 | 29 | 0.460 |
Why?
|
| Electron Probe Microanalysis | 1 | 2015 | 8 | 0.450 |
Why?
|
| Disease Models, Animal | 10 | 2020 | 2534 | 0.450 |
Why?
|
| Animals | 33 | 2020 | 28891 | 0.400 |
Why?
|
| Mice | 17 | 2020 | 12537 | 0.400 |
Why?
|
| Surface-Active Agents | 2 | 2017 | 62 | 0.390 |
Why?
|
| Phantoms, Imaging | 1 | 2015 | 490 | 0.380 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2013 | 82 | 0.380 |
Why?
|
| Glycoproteins | 3 | 2000 | 233 | 0.370 |
Why?
|
| Models, Molecular | 9 | 2005 | 1375 | 0.350 |
Why?
|
| Colitis | 2 | 2014 | 262 | 0.350 |
Why?
|
| Organometallic Compounds | 3 | 2013 | 148 | 0.320 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2020 | 630 | 0.300 |
Why?
|
| Neoplasm Invasiveness | 3 | 2020 | 580 | 0.270 |
Why?
|
| Tumor Burden | 2 | 2020 | 322 | 0.270 |
Why?
|
| Prostatic Hyperplasia | 2 | 2019 | 97 | 0.260 |
Why?
|
| Muramidase | 3 | 2017 | 37 | 0.260 |
Why?
|
| Escherichia coli | 5 | 2004 | 627 | 0.250 |
Why?
|
| Colonic Neoplasms | 3 | 2016 | 589 | 0.250 |
Why?
|
| Binding Sites | 9 | 2004 | 1167 | 0.240 |
Why?
|
| Calcium | 4 | 2002 | 1205 | 0.230 |
Why?
|
| Molecular Structure | 6 | 2007 | 310 | 0.210 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 2 | 2015 | 126 | 0.210 |
Why?
|
| Protein Conformation | 7 | 2004 | 935 | 0.210 |
Why?
|
| Cations, Divalent | 1 | 2003 | 39 | 0.200 |
Why?
|
| Pyrophosphatases | 1 | 2003 | 17 | 0.200 |
Why?
|
| Gadolinium | 3 | 2015 | 106 | 0.200 |
Why?
|
| Ions | 2 | 2000 | 80 | 0.200 |
Why?
|
| Neoplasm Transplantation | 3 | 2015 | 411 | 0.200 |
Why?
|
| Prostatic Neoplasms | 4 | 2019 | 1798 | 0.190 |
Why?
|
| Kinetics | 7 | 2004 | 1562 | 0.190 |
Why?
|
| Rats | 8 | 2013 | 4155 | 0.190 |
Why?
|
| Methyl Methanesulfonate | 1 | 2002 | 4 | 0.180 |
Why?
|
| Carboxypeptidases | 2 | 1994 | 34 | 0.180 |
Why?
|
| Neoplasms | 4 | 2020 | 3248 | 0.170 |
Why?
|
| Female | 14 | 2020 | 50028 | 0.170 |
Why?
|
| Polyethylene Glycols | 2 | 2017 | 376 | 0.170 |
Why?
|
| Cyclic N-Oxides | 3 | 1993 | 33 | 0.160 |
Why?
|
| Glutamic Acid | 1 | 2001 | 159 | 0.160 |
Why?
|
| Cattle | 4 | 2007 | 386 | 0.160 |
Why?
|
| Water | 4 | 2008 | 307 | 0.160 |
Why?
|
| Regional Blood Flow | 1 | 2020 | 197 | 0.160 |
Why?
|
| Organ Size | 1 | 2020 | 379 | 0.150 |
Why?
|
| Dietary Sugars | 1 | 2018 | 8 | 0.140 |
Why?
|
| Proton Magnetic Resonance Spectroscopy | 1 | 2018 | 12 | 0.140 |
Why?
|
| Cell Line, Tumor | 5 | 2016 | 2778 | 0.140 |
Why?
|
| Diet, Fat-Restricted | 1 | 2018 | 30 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 3 | 2017 | 3489 | 0.140 |
Why?
|
| Injections, Intravenous | 2 | 2015 | 238 | 0.140 |
Why?
|
| Mice, Transgenic | 3 | 2018 | 1645 | 0.140 |
Why?
|
| Ligands | 3 | 2016 | 478 | 0.130 |
Why?
|
| Urinary Bladder Neck Obstruction | 1 | 2017 | 26 | 0.130 |
Why?
|
| Weaning | 1 | 2017 | 26 | 0.130 |
Why?
|
| Catalysis | 5 | 2003 | 216 | 0.130 |
Why?
|
| Ethylenediamines | 1 | 2017 | 14 | 0.130 |
Why?
|
| Protein Unfolding | 1 | 2017 | 12 | 0.130 |
Why?
|
| Protein Aggregates | 1 | 2017 | 28 | 0.130 |
Why?
|
| Adiposity | 1 | 2017 | 76 | 0.130 |
Why?
|
| Fatty Acids | 1 | 2018 | 153 | 0.130 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2011 | 700 | 0.130 |
Why?
|
| ADAM17 Protein | 1 | 2016 | 9 | 0.130 |
Why?
|
| Chemokine CXCL2 | 1 | 2016 | 16 | 0.130 |
Why?
|
| Protein Denaturation | 2 | 2007 | 109 | 0.120 |
Why?
|
| Receptors, CXCR4 | 1 | 2016 | 49 | 0.120 |
Why?
|
| Simian virus 40 | 1 | 2015 | 36 | 0.120 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2015 | 48 | 0.120 |
Why?
|
| Carboxypeptidases A | 3 | 2007 | 11 | 0.110 |
Why?
|
| Carcinoma in Situ | 1 | 2015 | 53 | 0.110 |
Why?
|
| Muscle, Skeletal | 2 | 2010 | 483 | 0.110 |
Why?
|
| ErbB Receptors | 2 | 2016 | 513 | 0.110 |
Why?
|
| Image Processing, Computer-Assisted | 5 | 2014 | 1319 | 0.110 |
Why?
|
| Receptor Cross-Talk | 1 | 2014 | 33 | 0.110 |
Why?
|
| Epithelium | 1 | 2015 | 322 | 0.110 |
Why?
|
| Models, Animal | 1 | 2015 | 286 | 0.110 |
Why?
|
| Image Enhancement | 3 | 2020 | 565 | 0.110 |
Why?
|
| Renin-Angiotensin System | 1 | 2014 | 84 | 0.100 |
Why?
|
| Artifacts | 1 | 2015 | 252 | 0.100 |
Why?
|
| Glycolysis | 1 | 2015 | 191 | 0.100 |
Why?
|
| Diffusion | 1 | 2013 | 95 | 0.100 |
Why?
|
| Circular Dichroism | 3 | 2000 | 118 | 0.100 |
Why?
|
| Receptors, Calcitriol | 1 | 2014 | 131 | 0.100 |
Why?
|
| Acylation | 3 | 2004 | 68 | 0.100 |
Why?
|
| Radiography | 1 | 2015 | 826 | 0.100 |
Why?
|
| Neovascularization, Pathologic | 3 | 2012 | 354 | 0.100 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2014 | 166 | 0.100 |
Why?
|
| Penicillanic Acid | 2 | 2004 | 12 | 0.100 |
Why?
|
| Freezing | 2 | 2004 | 32 | 0.100 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2013 | 1267 | 0.100 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2013 | 63 | 0.100 |
Why?
|
| Solutions | 3 | 2005 | 86 | 0.100 |
Why?
|
| Positron-Emission Tomography | 1 | 2015 | 353 | 0.100 |
Why?
|
| Hydrolysis | 2 | 2004 | 146 | 0.090 |
Why?
|
| Niacinamide | 1 | 2012 | 102 | 0.090 |
Why?
|
| Phenylurea Compounds | 1 | 2012 | 99 | 0.090 |
Why?
|
| Microvessels | 2 | 2009 | 69 | 0.090 |
Why?
|
| Male | 8 | 2019 | 45863 | 0.090 |
Why?
|
| Solvents | 2 | 2002 | 91 | 0.090 |
Why?
|
| Mice, Nude | 2 | 2011 | 830 | 0.080 |
Why?
|
| Deuterium | 2 | 2001 | 35 | 0.080 |
Why?
|
| Blood Vessels | 1 | 2011 | 92 | 0.080 |
Why?
|
| Molecular Conformation | 3 | 2005 | 111 | 0.080 |
Why?
|
| Intestines | 1 | 2013 | 431 | 0.080 |
Why?
|
| X-Ray Microtomography | 1 | 2011 | 101 | 0.080 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2012 | 299 | 0.080 |
Why?
|
| Camellia sinensis | 1 | 2009 | 6 | 0.080 |
Why?
|
| Angiogenesis Modulating Agents | 1 | 2009 | 4 | 0.080 |
Why?
|
| Area Under Curve | 1 | 2010 | 340 | 0.080 |
Why?
|
| Serum Albumin | 1 | 2009 | 128 | 0.070 |
Why?
|
| Protein Structure, Secondary | 2 | 2017 | 342 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2012 | 611 | 0.070 |
Why?
|
| Humans | 12 | 2019 | 96105 | 0.070 |
Why?
|
| Protons | 3 | 2008 | 104 | 0.070 |
Why?
|
| Serum Albumin, Bovine | 1 | 2007 | 47 | 0.070 |
Why?
|
| Plant Extracts | 1 | 2009 | 248 | 0.070 |
Why?
|
| Brain Neoplasms | 1 | 2013 | 854 | 0.070 |
Why?
|
| Sensitivity and Specificity | 3 | 2009 | 2039 | 0.070 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2007 | 102 | 0.070 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2007 | 111 | 0.060 |
Why?
|
| Progesterone | 1 | 2007 | 112 | 0.060 |
Why?
|
| Drug Design | 1 | 2007 | 133 | 0.060 |
Why?
|
| Algorithms | 3 | 2010 | 2015 | 0.060 |
Why?
|
| Substrate Specificity | 3 | 2004 | 368 | 0.060 |
Why?
|
| Protein Binding | 3 | 2002 | 1560 | 0.060 |
Why?
|
| Pregnancy | 1 | 2013 | 3240 | 0.060 |
Why?
|
| Protein Renaturation | 1 | 2005 | 4 | 0.060 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 1828 | 0.060 |
Why?
|
| Receptor, Insulin | 1 | 2005 | 60 | 0.060 |
Why?
|
| Injections | 2 | 2017 | 126 | 0.060 |
Why?
|
| Stereoisomerism | 1 | 2005 | 104 | 0.060 |
Why?
|
| Chelating Agents | 1 | 2005 | 68 | 0.060 |
Why?
|
| Models, Biological | 2 | 2009 | 1809 | 0.060 |
Why?
|
| Reproducibility of Results | 4 | 2015 | 2880 | 0.060 |
Why?
|
| Structure-Activity Relationship | 2 | 2004 | 436 | 0.060 |
Why?
|
| Breast Neoplasms | 2 | 2017 | 3157 | 0.060 |
Why?
|
| Buffers | 1 | 2004 | 26 | 0.050 |
Why?
|
| Enterobacter cloacae | 1 | 2004 | 8 | 0.050 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2004 | 41 | 0.050 |
Why?
|
| Colorectal Neoplasms | 1 | 2012 | 1069 | 0.050 |
Why?
|
| Crystallography, X-Ray | 1 | 2005 | 527 | 0.050 |
Why?
|
| Manganese | 1 | 2003 | 57 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2004 | 509 | 0.050 |
Why?
|
| Hypoglycemic Agents | 1 | 2005 | 376 | 0.050 |
Why?
|
| Magnesium | 1 | 2003 | 178 | 0.050 |
Why?
|
| Cell Membrane | 1 | 2005 | 695 | 0.050 |
Why?
|
| Crohn Disease | 1 | 2009 | 806 | 0.050 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2009 | 647 | 0.050 |
Why?
|
| Calcium-Binding Proteins | 1 | 2002 | 120 | 0.050 |
Why?
|
| Chickens | 2 | 2017 | 213 | 0.050 |
Why?
|
| Surface Properties | 1 | 2002 | 131 | 0.040 |
Why?
|
| beta-Lactamase Inhibitors | 1 | 2001 | 3 | 0.040 |
Why?
|
| Penicillin G | 1 | 2001 | 4 | 0.040 |
Why?
|
| Asparagine | 1 | 2001 | 29 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2003 | 477 | 0.040 |
Why?
|
| Vanadium Compounds | 1 | 2000 | 2 | 0.040 |
Why?
|
| Cysteine | 1 | 2002 | 146 | 0.040 |
Why?
|
| Malonates | 1 | 2000 | 11 | 0.040 |
Why?
|
| Magnetics | 1 | 2000 | 43 | 0.040 |
Why?
|
| Anisotropy | 1 | 2000 | 65 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2001 | 282 | 0.040 |
Why?
|
| Mice, Inbred C3H | 1 | 2020 | 372 | 0.040 |
Why?
|
| beta-Lactams | 1 | 2000 | 15 | 0.040 |
Why?
|
| Mice, Knockout | 2 | 2015 | 2161 | 0.040 |
Why?
|
| Ultraviolet Rays | 1 | 2000 | 198 | 0.040 |
Why?
|
| Nitrogen | 1 | 2000 | 79 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2002 | 515 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2000 | 296 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2003 | 2090 | 0.040 |
Why?
|
| Molecular Sequence Data | 1 | 2003 | 3040 | 0.040 |
Why?
|
| Models, Theoretical | 1 | 2000 | 503 | 0.030 |
Why?
|
| Fructose | 1 | 2018 | 36 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2001 | 656 | 0.030 |
Why?
|
| Random Allocation | 1 | 2018 | 325 | 0.030 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2019 | 298 | 0.030 |
Why?
|
| Estradiol | 1 | 2017 | 255 | 0.030 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2016 | 50 | 0.030 |
Why?
|
| Spiro Compounds | 1 | 2016 | 30 | 0.030 |
Why?
|
| Metals | 1 | 1996 | 102 | 0.030 |
Why?
|
| Diet, Western | 1 | 2016 | 45 | 0.030 |
Why?
|
| In Vitro Techniques | 2 | 1994 | 1010 | 0.030 |
Why?
|
| Prostatectomy | 1 | 2019 | 480 | 0.030 |
Why?
|
| Kidney | 1 | 2000 | 1137 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 2 | 1994 | 750 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2017 | 489 | 0.030 |
Why?
|
| Breast | 1 | 2017 | 297 | 0.030 |
Why?
|
| Piperidines | 1 | 2016 | 171 | 0.030 |
Why?
|
| Cations | 1 | 1995 | 32 | 0.030 |
Why?
|
| Porphyrins | 1 | 1995 | 37 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 1619 | 0.030 |
Why?
|
| Snail Family Transcription Factors | 1 | 2014 | 48 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2016 | 3581 | 0.030 |
Why?
|
| Angiotensin II | 1 | 2014 | 95 | 0.030 |
Why?
|
| Chymotrypsin | 1 | 1994 | 28 | 0.030 |
Why?
|
| Succinates | 1 | 1994 | 25 | 0.030 |
Why?
|
| Amino Acids | 1 | 1995 | 262 | 0.030 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2014 | 115 | 0.030 |
Why?
|
| Oxyquinoline | 1 | 2013 | 4 | 0.030 |
Why?
|
| Mammography | 1 | 2017 | 475 | 0.030 |
Why?
|
| Cell Tracking | 1 | 2013 | 14 | 0.030 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2013 | 27 | 0.030 |
Why?
|
| Chemokine CXCL12 | 1 | 2013 | 38 | 0.030 |
Why?
|
| Gamma Rays | 1 | 2013 | 73 | 0.030 |
Why?
|
| Kidney Calculi | 1 | 1996 | 345 | 0.030 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2014 | 180 | 0.020 |
Why?
|
| Alcohol Dehydrogenase | 1 | 1993 | 42 | 0.020 |
Why?
|
| Perfusion | 1 | 2014 | 266 | 0.020 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 1993 | 17 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2014 | 465 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2013 | 528 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2015 | 565 | 0.020 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2011 | 48 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2012 | 376 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2019 | 10287 | 0.020 |
Why?
|
| Fluorescence | 1 | 2011 | 106 | 0.020 |
Why?
|
| Macrophages | 1 | 2014 | 623 | 0.020 |
Why?
|
| Glioma | 1 | 2013 | 321 | 0.020 |
Why?
|
| Angiography | 1 | 2011 | 209 | 0.020 |
Why?
|
| Peptides | 1 | 1994 | 671 | 0.020 |
Why?
|
| Hindlimb | 1 | 2010 | 97 | 0.020 |
Why?
|
| Disease Progression | 1 | 2014 | 1562 | 0.020 |
Why?
|
| Extremities | 1 | 2011 | 179 | 0.020 |
Why?
|
| Cell Movement | 1 | 2013 | 816 | 0.020 |
Why?
|
| Reference Values | 1 | 2010 | 674 | 0.020 |
Why?
|
| Recombinant Proteins | 2 | 2002 | 1034 | 0.020 |
Why?
|
| Gene Expression | 1 | 2013 | 1320 | 0.020 |
Why?
|
| Extracellular Space | 1 | 2009 | 90 | 0.020 |
Why?
|
| Spectrophotometry | 1 | 2008 | 108 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2014 | 1753 | 0.020 |
Why?
|
| Echo-Planar Imaging | 1 | 2008 | 52 | 0.020 |
Why?
|
| Fourier Analysis | 1 | 2008 | 128 | 0.020 |
Why?
|
| Liver | 1 | 1993 | 1238 | 0.020 |
Why?
|
| Aged | 2 | 2019 | 20968 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2009 | 819 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2009 | 938 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2014 | 1730 | 0.020 |
Why?
|
| Receptors, Progesterone | 1 | 2007 | 196 | 0.020 |
Why?
|
| Pyrones | 1 | 2005 | 8 | 0.010 |
Why?
|
| Glycogen Synthase | 1 | 2005 | 22 | 0.010 |
Why?
|
| 3T3-L1 Cells | 1 | 2005 | 35 | 0.010 |
Why?
|
| Electroporation | 1 | 2005 | 57 | 0.010 |
Why?
|
| Tyrosine | 1 | 2005 | 132 | 0.010 |
Why?
|
| Glycogen | 1 | 2005 | 59 | 0.010 |
Why?
|
| Middle Aged | 2 | 2019 | 28368 | 0.010 |
Why?
|
| Adult | 2 | 2019 | 28721 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2008 | 594 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2009 | 1158 | 0.010 |
Why?
|
| Adipocytes | 1 | 2005 | 170 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2005 | 692 | 0.010 |
Why?
|
| Amino Acids, Acidic | 1 | 2002 | 1 | 0.010 |
Why?
|
| Lithostathine | 1 | 2002 | 2 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2005 | 380 | 0.010 |
Why?
|
| Dialysis | 1 | 2002 | 24 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2005 | 1157 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 2002 | 147 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2002 | 336 | 0.010 |
Why?
|
| Deuterium Oxide | 1 | 2000 | 10 | 0.010 |
Why?
|
| Time Factors | 1 | 2009 | 5580 | 0.010 |
Why?
|
| Culture Media | 1 | 2000 | 150 | 0.010 |
Why?
|
| Static Electricity | 1 | 2000 | 97 | 0.010 |
Why?
|
| Tryptophan | 1 | 1994 | 105 | 0.010 |
Why?
|
| Alcohols | 1 | 1993 | 15 | 0.010 |
Why?
|
| Horses | 1 | 1993 | 36 | 0.010 |
Why?
|
| Oligopeptides | 1 | 1994 | 193 | 0.010 |
Why?
|
| Pyrrolidines | 1 | 1993 | 62 | 0.010 |
Why?
|
| Mutation | 1 | 2000 | 4374 | 0.000 |
Why?
|